SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001047469-17-003094
Filing Date
2017-05-01
Accepted
2017-05-01 16:02:56
Documents
8
Period of Report
2017-06-28
Effectiveness Date
2017-05-01

Document Format Files

Seq Description Document Type Size
1 DEF 14A a2232013zdef14a.htm DEF 14A 1228601
2 G777832.JPG g777832.jpg GRAPHIC 15386
3 G286766.JPG g286766.jpg GRAPHIC 7720
4 G337671.JPG g337671.jpg GRAPHIC 6998
5 G313218.JPG g313218.jpg GRAPHIC 72404
6 G132075.JPG g132075.jpg GRAPHIC 6324
7 G119342BGI001.GIF g119342bgi001.gif GRAPHIC 87967
8 G119342BGI002.GIF g119342bgi002.gif GRAPHIC 94487
  Complete submission text file 0001047469-17-003094.txt   1631962
Mailing Address 887 GREAT NORTHERN WAY SUITE 250 VANCOUVER A1 V5T 4T5
Business Address 887 GREAT NORTHERN WAY SUITE 250 VANCOUVER A1 V5T 4T5 6047077000
NOVELION THERAPEUTICS INC. (Filer) CIK: 0000827809 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 000-17082 | Film No.: 17800661
SIC: 2834 Pharmaceutical Preparations